Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Intra-Cellular Therapies Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -74.68M | -86.37M | -84.3M | -110.87M | -139.67M | -155.12M | -184.37M | -228.19M | -256.26M | -297.96M | -321.36M | -303.5M | -284.13M | -259.09M | -237.37M | -232.34M |
Depreciation & Amortization | 508K | 535K | 532K | 526K | 528K | 535K | 570K | 619K | 656K | 659.83K | 623.77K | 577.35K | 533.36K | 512.51K | 499.61K | 506.32K |
Stock-Based Compensation | 64.03M | 62.56M | 59.38M | 56.24M | 52.83M | 49.13M | 46.58M | 45.35M | 43.01M | 41.23M | 39.01M | 35.63M | 34.3M | 29.69M | 27.06M | 25.39M |
Other Working Capital | -1.33M | 23.86M | 23M | 33.72M | 59.41M | 37.72M | 43.75M | 29.18M | 11.16M | 11.13M | 9.07M | -3.85M | 740.84K | -10.93M | -19.5M | 1.82M |
Other Non-Cash Items | 49.76M | 52.76M | 54.61M | 29.41M | -1.65M | -482K | -253K | 2.88M | 538K | -613.66K | -827.93K | -3.93M | 178.53K | -264.88M | -264.87M | -264.87M |
Deferred Income Tax | n/a | -2.54M | -4.73M | -6.66M | -6.66M | -4.12M | -1.93M | -1K | -1K | -779.78K | -2.37M | -2.99M | -4.08M | 261.31M | 263.06M | 263.64M |
Change in Working Capital | -54.1M | -30.39M | -27.68M | -35.23M | -29.58M | -51.27M | -50M | -68.06M | -58.14M | -46.71M | -45.16M | -20.4M | -6.35M | -22.14M | -27.3M | -18.95M |
Operating Cash Flow | -73.18M | -62.16M | -60.91M | -98.25M | -124.2M | -161.33M | -189.41M | -247.4M | -270.19M | -304.18M | -330.09M | -294.63M | -259.54M | -254.6M | -238.91M | -226.61M |
Capital Expenditures | -322K | -750K | -322K | -269K | -269K | -240K | -89K | -212K | -778K | -807.24K | -999.49K | -891.74K | -325.74K | -399.26K | -259.92K | -244.68K |
Cash Acquisitions | n/a | -19.9M | n/a | n/a | n/a | -30.34M | -156.52M | -193.87M | -193.87M | -143.64M | -37.35M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -739.68M | -586.54M | -410.43M | -387.86M | -415.27M | -426.31M | -380.84M | -40.95M | -759.21M | -713.09M | -657.46M | -1.02B | -224.57M | -422.3M | -590.93M | -579.31M |
Sales Maturities Of Investments | 404.85M | 449.45M | 461.95M | 526.31M | 521.08M | 534.93M | 615.65M | 218.37M | 631.61M | 586.77M | 488.93M | 860.07M | 505.24M | 475.2M | 436.7M | 368.51M |
Other Investing Acitivies | 24M | 71.42M | 51.52M | 138.45M | 105.81M | 108.62M | 234.81M | 177.41M | -127.59M | -126.32M | -168.53M | -157.07M | 280.67M | 52.9M | -154.23M | -210.8M |
Investing Cash Flow | -335.15M | -137.84M | 51.2M | 138.18M | 105.54M | 108.38M | 234.72M | 177.2M | -128.37M | -127.13M | -169.53M | -157.96M | 280.34M | 52.5M | -154.49M | -211.04M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 567.51M | 564.91M | 560.75M | 24.16M | 17.81M | 16.99M | 20.07M | 16.98M | 21.43M | 27.16M | 21.51M | 16M | 7.91M | 3.64M | 6.29M | 10.77M |
Financial Cash Flow | 567.51M | 564.91M | 560.75M | 24.16M | 17.81M | 16.99M | 20.07M | 16.98M | 455.16M | 460.89M | 455.82M | 451.9M | 11.52M | 7.24M | 385.14M | 388.04M |
Net Cash Flow | 159.18M | 364.91M | 551.05M | 64.09M | -848K | -35.96M | 65.37M | -53.22M | 56.6M | 29.58M | -43.8M | -684.9K | 32.32M | -194.86M | -8.26M | -49.61M |
Free Cash Flow | -73.5M | -62.91M | -61.23M | -98.52M | -124.47M | -161.57M | -189.5M | -247.62M | -270.96M | -304.98M | -331.09M | -295.52M | -259.87M | -255M | -239.17M | -226.86M |